Anat Naschitz is a Managing Director at OrbiMed, a preeminent global healthcare investment firm with ~$15 billion under management across public and private asset classes. The firm covers the entire healthcare spectrum, investing in biopharmaceuticals, medical devices and digital health. Anat has over 20 years of healthcare experience, and currently serves on the boards of biotech, medical device and digital health companies.
Prior experience includes seven years with McKinsey & Company in London, where Anat was an Associate Partner, managing strategy and M&A projects for senior management of the world’s preeminent pharmaceutical and biotechnology companies. Among other accomplishments, Anat led pharmaceutical spinout work resulting in the creation of European biotech companies, one of which currently trades at >$3bn. Post McKinsey Anat joined Apax Partners, where she focused on life sciences investments.
She earned her M.B.A. at INSEAD and her LL.B. at Tel Aviv University.